Wu X - Search Results

1

Enhancement of death receptor 4-mediated apoptosis and cytotoxicity in renal cell carcinoma cells by anisomycin.

Li Y, Wu X, Jin X, Wang J, Togo Y, Suzuki T, Hashimoto T, Yamada Y, Nakanishi Y, Kanematsu A, Nojima M, Kakehi Y, Yamamoto S. Li Y, et al. Among authors: wu x. Anticancer Drugs. 2017 Feb;28(2):180-186. doi: 10.1097/CAD.0000000000000450. Anticancer Drugs. 2017. PMID: 27879498

2

[Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].

Wu XX, Mizutani Y, Kakehi Y, Nakamura E, Mitsumori K, Takahashi T, Terachi T, Okada Y, Yoshida O. Wu XX, et al. Hinyokika Kiyo. 1998 Sep;44(9):621-6. Hinyokika Kiyo. 1998. PMID: 9805665 Free article. Japanese.

3

Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.

Mizutani Y, Wu XX, Yoshida O, Shirasaka T, Bonavida B. Mizutani Y, et al. Among authors: wu xx. Oncol Rep. 1999 Sep-Oct;6(5):979-82. doi: 10.3892/or.6.5.979. Oncol Rep. 1999. PMID: 10425290

4

Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.

Wu XX, Kakehi Y, Takahashi T, Habuchi T, Ogawa O. Wu XX, et al. Int J Urol. 2000 Jun;7(6):210-7. doi: 10.1046/j.1442-2042.2000.00178.x. Int J Urol. 2000. PMID: 10843452 Free article. Clinical Trial.

5

Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.

Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O. Wu XX, et al. Cancer Res. 2000 Jun 1;60(11):2912-8. Cancer Res. 2000. PMID: 10850437

6

Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.

Lu JJ, Kakehi Y, Takahashi T, Wu XX, Yuasa T, Yoshiki T, Okada Y, Terachi T, Ogawa O. Lu JJ, et al. Among authors: wu xx. Clin Cancer Res. 2000 Aug;6(8):3166-71. Clin Cancer Res. 2000. PMID: 10955799

7

Increased intracellular doxorubicin by anti-FAS monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells.

Wu X, Kakehi Y, Mizutani Y, Terachi T, Ogawa O. Wu X, et al. Urology. 2001 May;57(5):993-8. doi: 10.1016/s0090-4295(01)00947-5. Urology. 2001. PMID: 11337314

8

Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil.

Wu XX, Kakehi Y, Mizutani Y, Lu J, Terachi T, Ogawa O. Wu XX, et al. Int J Oncol. 2001 Jul;19(1):19-24. doi: 10.3892/ijo.19.1.19. Int J Oncol. 2001. PMID: 11408917

9

Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.

Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y, Terachi T, Ogawa O. Wu XX, et al. Int J Oncol. 2002 May;20(5):949-54. Int J Oncol. 2002. PMID: 11956588

10

Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells.

Wu XX, Kakehi Y, Mizutani Y, Nishiyama H, Kamoto T, Megumi Y, Ito N, Ogawa O. Wu XX, et al. Int J Cancer. 2003 Apr 20;104(4):409-17. doi: 10.1002/ijc.10948. Int J Cancer. 2003. PMID: 12584736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,221 results

Search Page

Filters